A method for monitoring the dispensing of a drop by a device for dispensing a liquid product in the form of drops uses a detector for detecting a liquid product arranged near an orifice for dispensing drops, and a system for processing information provided by the detector. The processing system receives information corresponding to the series of steps: detecting the presence of liquid, wherein the detector detects the presence of liquid near the dispensing orifice, the detector configured such that detection of the presence of liquid is indicative of a drop in the course of being formed, in contact with the dispensing orifice, and detecting an absence of liquid, wherein the detector detects the absence of liquid near the dispensing orifice, and the processing system processes the series of information on detection of the presence and absence of liquid in order to provide information on the dispensing of a drop.

A drug delivery device includes a drug delivery assembly configured to receive a portion of a head of a patient and mounted to a helmet or support. The drug delivery assembly includes one or more imaging devices configured to have an eye of the patient in a field of view thereof, an injection assembly configured to receive a drug to be injected, and a staging assembly including one or more actuators configured to position the injection assembly relative to the eye of the patient. A controller receives one or more images from the one or more imaging devices; detects a location of a limbus of the eye of the patient in the one or more images; and activate the one or more actuators to drive a needle into a placement location on the eye of the patient and dispense a drug into the eye through the needle.

An ocular implant including a drug releasing element and having an inlet portion and a Schlemm's canal portion distal to the inlet portion, the inlet portion being disposed at a proximal end of the implant and sized and configured to be placed within an anterior chamber of a human eye, the Schlemm's canal portion being arranged and configured to be disposed within Schlemm's canal of the eye when the inlet portion is disposed in the anterior chamber.

A therapeutic device for extended release drug delivery including a refillable reservoir configured to receive a therapeutic agent and having an outlet for delivery of the therapeutic agent to a patient from the reservoir over an extended period. A porous structure is coupled near the outlet of the reservoir, the porous structure formed of sintered material. A barrier layer is coupled to the reservoir on or adjacent a surface of the porous structure such that the therapeutic agent passes through both the porous structure and the barrier layer upon delivery from the reservoir through the outlet. The porous structure is tuned to deliver the therapeutic agent at a diffusion rate and the barrier layer is adapted to block passage of particles having an average particle size within an average particle size range that is outside an average particle size range blocked by the porous structure. Related methods and systems are provided.

A nozzle unit for cross-linking of eye tissue is disclosed. The nozzle unit comprises a dosing device for providing a predefined dose of a photosensitizer, a pressure-generating device for generating a pressure in the dosing device, and an outlet nozzle for discharging the dose of the photosensitizer, in a puff-type manner and in the form of at least one stream or stream bundle, through an outlet opening of the outlet nozzle.

An implant for insertion through a punctum and into a canalicular lumen of a patient. The implant includes a matrix of material, a therapeutic agent dispersed in the matrix of material, a sheath disposed over a portion of the matrix of material and configured to inhibit the therapeutic agent from being released from the matrix of material into the canalicular lumen and to allow the therapeutic agent to be released from a surface of the matrix of material to a tear film, and a retention structure configured to retain the implant within the canalicular lumen.

Drug formulations, devices and methods are provided to deliver biologically active substances to the eye. The formulations are delivered into scleral tissues adjacent to or into the suprachoroidal space without damage to the underlying choroid. One class of formulations is provided wherein the formulation is localized in the suprachoroidal space near the region into which it is administered. Another class of formulations is provided wherein the formulation can migrate to another region of the suprachoroidal space, thus allowing an injection in the anterior region of the eye in order to treat the posterior region.

This application is related to a head-mounted display system and related methods for entertainment, diagnostics, and treatment. The HMD includes various sensors and tools to take physical measurements, perform physical procedures, adjust physical conditions, or manipulate digital data. In some embodiments, the HMD produces different types of sensory stimuli, such as releasing or filtering certain compounds in liquid or aqueous forms in the space near the HMD, or adjusting different physical features of the space near the HMD, such as temperature and flow, to enhance the augmented or virtual reality environment being displayed. In some embodiments, the HMD performs regular monitoring, a specific examination, a surgical intervention, or other care procedures on the eyes automatically or in conjunction with a device of an eye care professional across a computer network to care for the user's eyes in real time or on an ongoing basis.

An injection device for injecting a product into an eye, said device comprising an injection needle and a support on which the injection needle is fixed, said device being characterized in that it comprises a locating mark disposed in such a way that the latter can be placed in contact with a defined bearing region of the surface of the eye, before any contact of the injection needle with said surface, and can then be kept in contact with said bearing region during a stage of penetration of said injection needle through said surface of the eye.

A system and method for assisting a surgeon performing an ophthalmic procedure on an eye of a patient, the system including a lubrication assembly. The lubrication assembly may be disposed on a proximal end of a robotic arm, a proximal end of a surgical microscope, or a proximal end of a mobile stand or frame. Dispersal of lubricant from the lubrication assembly may be upon receipt of a direct input from a surgeon, according to a predetermined schedule, or according to an image processing protocol. The lubrication assembly may be moved into position over the eye of the patient manually by the surgeon or through the indirect command of a motion controller which is operable to move the robotic arm or the surgical microscope so as to extend the lubrication assembly into a desired position.